Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization via Inhibition of VEGF Production

Neovascularization (NV) of the cornea disrupts vision which leads to blindness. Investigation of antiangiogenic, slow-release and biocompatible approaches for treating corneal NV is of great importance. We designed an eye drop formulation containing gelatin/epigallocatechin-3-gallate (EGCG) nanopart...

全面介紹

Na minha lista:
書目詳細資料
發表在:Pharmaceutics
Main Authors: Miyagawa, Takuya, Chen, Zhi-Yu, Chang, Che-Yi, Chen, Ko-Hua, Wang, Yang-Kao, Liu, Guei-Sheung, Tseng, Ching-Li
格式: Artigo
語言:Inglês
出版: MDPI 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284559/
https://ncbi.nlm.nih.gov/pubmed/32354067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12050404
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍